Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Sarcoma 180 D012510 21 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Melanoma D008545 69 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Proteinuria D011507 30 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Psoriasis D011565 47 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Nerve Degeneration D009410 53 associated lipids
Hypertension D006973 115 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Hyperalgesia D006930 42 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Cardiomyopathies D009202 10 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenoma D000236 40 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Vascular Diseases D014652 16 associated lipids
Ovarian Diseases D010049 5 associated lipids
Anemia D000740 21 associated lipids
Glioblastoma D005909 27 associated lipids
Fabry Disease D000795 4 associated lipids
Influenza, Human D007251 11 associated lipids
Retinal Detachment D012163 10 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Atherosclerosis D050197 85 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Insulin Resistance D007333 99 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Endotoxemia D019446 27 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Acute Lung Injury D055371 33 associated lipids
Sensation Disorders D012678 2 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Neuralgia D009437 28 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Lung Injury D055370 14 associated lipids
Teratocarcinoma D018243 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Ileus D045823 3 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Garris CS et al. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. 2013 Nat. Immunol. pmid:24076635
Mierzejewska K et al. Sphingosine-1-phosphate-mediated mobilization of hematopoietic stem/progenitor cells during intravascular hemolysis requires attenuation of SDF-1-CXCR4 retention signaling in bone marrow. 2013 Biomed Res Int pmid:24490172
Liu Y et al. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors. 2013 J. Pathol. pmid:23839903
Yasuo M et al. Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate. 2013 PLoS ONE pmid:23326540
Fukuhara S and Mochizuki N [Lymphocytes mobilization into blood regulated by Spns2, a sphingosine 1-phosphate transporter, expressed on endothelial cells]. 2013 Seikagaku pmid:23717873
Takuwa Y et al. Sphingosine-1-phosphate signaling in physiology and diseases. 2012 Sep-Oct Biofactors pmid:22674845
Iwaki S et al. Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells. 2012 Nov-Dec Biochim. Biophys. Acta pmid:22819712
Fournie P et al. Sphingosine-1 phosphate prevents ethanol-induced corneal epithelial apoptosis. 2012 Mar-Apr Indian J Ophthalmol pmid:22446906
Tse KW et al. Small molecule inhibitors of the Pyk2 and FAK kinases modulate chemoattractant-induced migration, adhesion and Akt activation in follicular and marginal zone B cells. 2012 Jan-Feb Cell. Immunol. pmid:22507871
Pyne NJ et al. Sphingosine 1-phosphate signalling in cancer. 2012 Biochem. Soc. Trans. pmid:22260672
Jin YX et al. A strategy for enrichment of the bioactive sphingoid base-1-phosphates produced by Hypericum perforatum L. in a balloon type airlift reactor. 2012 Bioresour. Technol. pmid:22940331
Snider AJ et al. Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease. 2012 Prostaglandins Other Lipid Mediat. pmid:22940715
Moon MH et al. Sphingosine-1-phosphate inhibits interleukin-1β-induced inflammation in human articular chondrocytes. 2012 Int. J. Mol. Med. pmid:22992945
Park TS and Goldberg IJ Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure. 2012 Heart Fail Clin pmid:22999245
Ihlefeld K et al. Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. 2012 Biochem. J. pmid:22908849
Cyster JG and Schwab SR Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. 2012 Annu. Rev. Immunol. pmid:22149932
Kurata H et al. Structure-activity relationship studies of S1P agonists with a dihydronaphthalene scaffold. 2012 Bioorg. Med. Chem. Lett. pmid:22153936
Calise S et al. Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: role of S1P receptors. 2012 Biochim. Biophys. Acta pmid:22178384
Balczerski B et al. Analysis of sphingosine-1-phosphate signaling mutants reveals endodermal requirements for the growth but not dorsoventral patterning of jaw skeletal precursors. 2012 Dev. Biol. pmid:22185793
Witt W et al. Sphingosine-1-phosphate induces contraction of valvular interstitial cells from porcine aortic valves. 2012 Cardiovasc. Res. pmid:22232739
Madhunapantula SV et al. Targeting sphingosine kinase-1 to inhibit melanoma. 2012 Pigment Cell Melanoma Res pmid:22236408
Che W et al. Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells. 2012 Biochim. Biophys. Acta pmid:22743041
Testai FD et al. Changes in the cerebrospinal fluid ceramide profile after subarachnoid hemorrhage. 2012 Stroke pmid:22713492
García-Merino JA and Sánchez AJ [Basic mechanisms of action of fingolimod in relation to multiple sclerosis]. 2012 Rev Neurol pmid:22718407
Hisano Y et al. Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. 2012 PLoS ONE pmid:22723910
Chiba K and Yoshii N [Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis]. 2012 Nippon Yakurigaku Zasshi pmid:22728990
Linke B et al. Analysis of sphingolipid and prostaglandin synthesis during zymosan-induced inflammation. 2012 Prostaglandins Other Lipid Mediat. pmid:22732087
Yokoyama K et al. Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet. 2012 Clin. Nephrol. pmid:22732343
Czarnota GJ et al. Tumor radiation response enhancement by acoustical stimulation of the vasculature. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22778441
Park SW et al. Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. 2012 J. Am. Soc. Nephrol. pmid:22095950
Liu X et al. Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells. 2012 Mol. Cell. Biochem. pmid:22113622
Liu X et al. ABCA1, ABCG1, and SR-BI: Transit of HDL-associated sphingosine-1-phosphate. 2012 Clin. Chim. Acta pmid:22115863
Juarez JG et al. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice. 2012 Blood pmid:22049516
von Bismarck P et al. IKK NBD peptide inhibits LPS induced pulmonary inflammation and alters sphingolipid metabolism in a murine model. 2012 Pulm Pharmacol Ther pmid:22469869
El-Shewy HM et al. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. 2012 Mol. Endocrinol. pmid:22422617
Eisenhoffer GT et al. Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia. 2012 Nature pmid:22504183
Peng P et al. [Effect of sphingosine-1-phosphate on chemotherapy-induced ovarian damage and on the efficacy of chemotherapy in mice bearing S180 tumor]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:22445989
Podbielska M et al. Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis. 2012 Neurochem. Res. pmid:22451227
Altay O et al. Isoflurane delays the development of early brain injury after subarachnoid hemorrhage through sphingosine-related pathway activation in mice. 2012 Crit. Care Med. pmid:22488000
Tian YL et al. [Research progress of the selective sphingosine-1-phosphate receptor 1 agonists]. 2012 Yao Xue Xue Bao pmid:22493799
Makino Y et al. Role of sphingosine-1-phosphate inβ-adrenoceptor desensitization via Ca(2+) sensitization in airway smooth muscle. 2012 Allergol Int pmid:22441633
Shi Y et al. Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion. 2012 J. Hepatol. pmid:21756852
Spiegel S et al. Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy. 2012 Oncogene pmid:21725353
Krishna SM et al. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. 2012 Am. J. Pathol. pmid:22698985
Lee SH et al. Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans. 2012 J. Clin. Endocrinol. Metab. pmid:22679064
Kim CH et al. Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors. 2012 Leukemia pmid:21769103
Ponnusamy S et al. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. 2012 EMBO Mol Med pmid:22707406
Kunisawa J and Kiyono H Immunological function of sphingosine 1-phosphate in the intestine. 2012 Nutrients pmid:22666543
Yang J et al. Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-α-dependent activation of sphingosine-1-phosphate signaling. 2012 Circulation pmid:22668972
Obinata H and Hla T Sphingosine 1-phosphate in coagulation and inflammation. 2012 Semin Immunopathol pmid:21805322
Tencé M et al. Increased interaction of connexin43 with zonula occludens-1 during inhibition of gap junctions by G protein-coupled receptor agonists. 2012 Cell. Signal. pmid:21872657
Beech DJ Integration of transient receptor potential canonical channels with lipids. 2012 Acta Physiol (Oxf) pmid:21624095
Liu W et al. S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition. 2012 Exp. Cell Res. pmid:22406263
Fukuhara S et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. 2012 J. Clin. Invest. pmid:22406534
Yang F et al. Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis. 2012 Cancer Biol. Ther. pmid:22406995
Kwak HI et al. Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation. 2012 Angiogenesis pmid:22407449
Singh AT et al. Sphingosine-sphingosine-1-phosphate pathway regulates trophoblast differentiation and syncytialization. 2012 Reprod. Biomed. Online pmid:22197131
Pitman MR et al. Molecular targets of FTY720 (fingolimod). 2012 Curr. Mol. Med. pmid:22834825
Curry FE et al. Erythrocyte-derived sphingosine-1-phosphate stabilizes basal hydraulic conductivity and solute permeability in rat microvessels. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22865384
Masuko K et al. Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: a possible new role in arthritis. 2012 Int J Rheum Dis pmid:22898216
Schmitz EI et al. Sphingosine 1-phosphate protects primary human keratinocytes from apoptosis via nitric oxide formation through the receptor subtype S1P₃. 2012 Mol. Cell. Biochem. pmid:22899173
Egom EE A therapeutic approach to hyperglycaemia in the setting of acute myocardial infarction: spotlight on glucagon-like peptide 1. 2012 Ther Adv Cardiovasc Dis pmid:22902834
Liu Q et al. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats. 2012 PLoS ONE pmid:22848628
Asghar MY et al. Sphingosine 1-phosphate and human ether-a'-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells. 2012 Endocr. Relat. Cancer pmid:22889737
Kim BJ et al. Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women. 2012 J. Clin. Endocrinol. Metab. pmid:22879631
Knapp M et al. Myocardial infarction changes sphingolipid metabolism in the uninfarcted ventricular wall of the rat. 2012 Lipids pmid:22833182
Beckham TH et al. Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B. 2012 Int. J. Cancer pmid:22322590
Törnquist K Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells. 2012 Acta Physiol (Oxf) pmid:21338471
Brizuela L et al. First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer. 2012 Mol. Cancer Ther. pmid:22784711
Babahosseini H et al. Roles of bioactive sphingolipid metabolites in ovarian cancer cell biomechanics. 2012 Conf Proc IEEE Eng Med Biol Soc pmid:23366417
Salata D et al. [Sphingosine-1-phosphate--molecular maestro]. 2012 Postepy Biochem. pmid:23373414
Japtok L et al. Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype. 2012 PLoS ONE pmid:23145172
Härmä V et al. Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models. 2012 Oncogene pmid:21996742
Zhang L et al. A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. 2012 J. Exp. Med. pmid:23148237
Qiao Y et al. Sphingosine 1-phosphate elicits proinflammatory responses in ARPE-19 cells. 2012 Invest. Ophthalmol. Vis. Sci. pmid:23150617
Bhattacharya M et al. IQGAP1 is necessary for pulmonary vascular barrier protection in murine acute lung injury and pneumonia. 2012 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:22561460
Spohr TC et al. Sphingosine 1-phosphate-primed astrocytes enhance differentiation of neuronal progenitor cells. 2012 J. Neurosci. Res. pmid:22588662
Parrill AL et al. Structure of the first sphingosine 1-phosphate receptor. 2012 Sci Signal pmid:22623751
Trifilieff A and Fozard JR Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor. 2012 J. Pharmacol. Exp. Ther. pmid:22570366
Van Brocklyn JR and Williams JB The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. 2012 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:22613819
Ma Y et al. Sphingosine-1-phosphate (S1P) mediates darkness-induced stomatal closure through raising cytosol pH and hydrogen peroxide (Hâ‚‚Oâ‚‚) levels in guard cells in Vicia faba. 2012 Sci China Life Sci pmid:23090064
Loh KC et al. Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway. 2012 PLoS ONE pmid:22606352
Taniguchi M et al. Regulation of autophagy and its associated cell death by "sphingolipid rheostat": reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway. 2012 J. Biol. Chem. pmid:23035115
Kawashima T et al. Contrary effects of sphingosine-1-phosphate on expression of α-smooth muscle actin in transforming growth factor β1-stimulated lung fibroblasts. 2012 Eur. J. Pharmacol. pmid:23041148
Sorci-Thomas MG and Thomas MJ High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:23077142
Yonesu K and Nara F [Anti-angiogenic effect of bioactive lipid antagonists]. 2012 Nippon Rinsho pmid:23513926
Lim M et al. The role of sphingosine kinase 1/sphingosine-1-phosphate pathway in the myogenic tone of posterior cerebral arteries. 2012 PLoS ONE pmid:22532844
Lynch KR Building a better sphingosine kinase-1 inhibitor. 2012 Biochem. J. pmid:22533672
Mann DL Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers. 2012 Circulation pmid:22534620
Meissner A et al. Tumor necrosis factor-α-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure. 2012 Circulation pmid:22534621
Callihan P et al. Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells. 2012 Neuropharmacology pmid:22016110
Maceyka M et al. Sphingosine-1-phosphate signaling and its role in disease. 2012 Trends Cell Biol. pmid:22001186
Gupta VK et al. Focus on molecules: Sphingosine 1 Phosphate (S1P). 2012 Exp. Eye Res. pmid:22001715
Lim KG et al. Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival. 2012 Br. J. Pharmacol. pmid:22251058
Canals D et al. Protein phosphatase 1α mediates ceramide-induced ERM protein dephosphorylation: a novel mechanism independent of phosphatidylinositol 4, 5-biphosphate (PIP2) and myosin/ERM phosphatase. 2012 J. Biol. Chem. pmid:22311981
Knapp M et al. Decreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failure. 2012 Adv Med Sci pmid:22296975
Nagahashi M et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. 2012 Cancer Res. pmid:22298596
Ratajczak J et al. A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient. 2012 Leukemia pmid:22343521
Mascall KS et al. Sphingosine-1-phosphate-induced release of TIMP-2 from vascular smooth muscle cells inhibits angiogenesis. 2012 J. Cell. Sci. pmid:22344262
Hsu A et al. Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells. 2012 Int. J. Oncol. pmid:22344462